CS221809B2 - Method of making the dextrorotary trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido/4,3-b/indole - Google Patents

Method of making the dextrorotary trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido/4,3-b/indole Download PDF

Info

Publication number
CS221809B2
CS221809B2 CS815712A CS571281A CS221809B2 CS 221809 B2 CS221809 B2 CS 221809B2 CS 815712 A CS815712 A CS 815712A CS 571281 A CS571281 A CS 571281A CS 221809 B2 CS221809 B2 CS 221809B2
Authority
CS
Czechoslovakia
Prior art keywords
formula
trans
residue
compounds
pyrido
Prior art date
Application number
CS815712A
Other languages
Czech (cs)
English (en)
Inventor
Willard M Welch
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of CS221809B2 publication Critical patent/CS221809B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/09—Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42—Separation; Purification; Stabilisation; Use of additives
    • C07C51/487—Separation; Purification; Stabilisation; Use of additives by treatment giving rise to chemical modification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
CS815712A 1979-01-23 1980-01-03 Method of making the dextrorotary trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido/4,3-b/indole CS221809B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/005,698 US4224329A (en) 1979-01-23 1979-01-23 2-Substituted-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indoles

Publications (1)

Publication Number Publication Date
CS221809B2 true CS221809B2 (en) 1983-04-29

Family

ID=21717248

Family Applications (4)

Application Number Title Priority Date Filing Date
CS8098A CS221806B2 (en) 1979-01-23 1980-01-03 Method of making the trans-2-substituted-5-aryl-2,3,4,4a5, 98-hexahydro-1h-pyrido/1,3-b/indole
CS815710A CS221807B2 (en) 1979-01-23 1980-01-03 Method of making the trans-2-substituted-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido/4,3b/indole
CS815711A CS221808B2 (en) 1979-01-23 1980-01-03 Method of making the 5-phenyl-2-hydroxytetrahydrofurane
CS815712A CS221809B2 (en) 1979-01-23 1980-01-03 Method of making the dextrorotary trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido/4,3-b/indole

Family Applications Before (3)

Application Number Title Priority Date Filing Date
CS8098A CS221806B2 (en) 1979-01-23 1980-01-03 Method of making the trans-2-substituted-5-aryl-2,3,4,4a5, 98-hexahydro-1h-pyrido/1,3-b/indole
CS815710A CS221807B2 (en) 1979-01-23 1980-01-03 Method of making the trans-2-substituted-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido/4,3b/indole
CS815711A CS221808B2 (en) 1979-01-23 1980-01-03 Method of making the 5-phenyl-2-hydroxytetrahydrofurane

Country Status (34)

Country Link
US (1) US4224329A (de)
JP (4) JPS55100386A (de)
KR (1) KR830001932A (de)
AR (1) AR231291A1 (de)
AT (1) AT376674B (de)
AU (1) AU521986B2 (de)
BE (1) BE881283A (de)
CA (1) CA1144168A (de)
CH (2) CH648314A5 (de)
CS (4) CS221806B2 (de)
DD (2) DD149071A5 (de)
DE (1) DE3002367A1 (de)
DK (1) DK25580A (de)
EG (1) EG14767A (de)
FI (1) FI800179A (de)
FR (3) FR2447379A1 (de)
GB (1) GB2041925B (de)
GR (1) GR73567B (de)
HU (3) HU189174B (de)
IE (1) IE49500B1 (de)
IL (1) IL59189A (de)
IN (1) IN153300B (de)
IT (1) IT1149927B (de)
LU (1) LU82105A1 (de)
NL (1) NL8000385A (de)
NO (2) NO151895C (de)
NZ (3) NZ192175A (de)
PH (4) PH15736A (de)
PL (4) PL120774B1 (de)
PT (1) PT70724A (de)
SE (3) SE441358B (de)
SU (3) SU1168094A3 (de)
YU (2) YU269379A (de)
ZA (1) ZA796374B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4337250A (en) * 1979-07-30 1982-06-29 Pfizer Inc. Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
US4431646A (en) * 1979-07-30 1984-02-14 Pfizer Inc. Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
US4432978A (en) * 1979-07-30 1984-02-21 Pfizer Inc. Hexahydro-trans-pyridoindole
US4431649A (en) * 1979-07-30 1984-02-14 Pfizer Inc. Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
US4427679A (en) 1981-01-16 1984-01-24 Pfizer Inc. Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
US4467090A (en) * 1982-09-30 1984-08-21 Pfizer Inc. Compound, 8-fluoro-5-(p-fluorophenyl)-2-[4-(p-fluorophenyl)-4-hydroxybutyryl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole
US4477669A (en) * 1982-09-30 1984-10-16 Pfizer Inc. Processes and intermediates useful in the preparation of flutroline
US4451655A (en) * 1982-05-17 1984-05-29 Pfizer Inc. Process for preparing carboline derivatives and compounds used in their preparation
US4568748A (en) * 1982-09-30 1986-02-04 Pfizer Inc. 2-Carbobenzoxy-8-fluoro-5-(p-fluorophenyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole
US4698444A (en) * 1982-09-30 1987-10-06 Pfizer Inc. 1,1-bis(p-fluorophenyl)urea
JPS61248502A (ja) * 1985-04-26 1986-11-05 Pioneer Electronic Corp 磁性材料の接合方法
US4672117A (en) * 1985-09-16 1987-06-09 American Home Products Corporation Antipsychotic gamma-carbolines
US4636563A (en) * 1985-09-16 1987-01-13 American Home Products Corporation Antipsychotic γ-carbolines
US4798896A (en) * 1988-01-19 1989-01-17 American Home Products Corporation Antipsychotic gamma-carboline N-oxides
US5075315A (en) * 1990-05-17 1991-12-24 Mcneilab, Inc. Antipsychotic hexahydro-2H-indeno[1,2-c]pyridine derivatives
ID28967A (id) * 1998-12-21 2001-07-19 Janssen Pharmaceutica Nv Benzisoksazol dan fenon sebagai alfa 2-antagonis
RU2329044C1 (ru) * 2006-11-16 2008-07-20 Андрей Александрович Иващенко Лиганды 5-ht6 рецепторов, фармацевтическая композиция, способ ее получения и лекарственное средство

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA551241A (en) * 1958-01-07 S. Abbott Leslie Production of substituted piperidines
US3382250A (en) * 1966-12-07 1968-05-07 Abbott Lab Aroylalkyl derivatives of 1, 2, 3, 4-tetrahydro-5h-pyrido[4, 3b]indoles
US3687961A (en) * 1971-05-03 1972-08-29 Abbott Lab 8-fluoro-2-{8 3-(4-fluorophenylanilinopropyl{9 -gamma-carboline
AR205452A1 (es) * 1973-12-06 1976-05-07 Endo Lab Metodo para preparar nuevos trans-2, 3, 4, 4a, 5, 9b-hexahidro-5-fenil-1h-pirido(4,3-b) indoles
JPS50126699A (de) * 1974-03-20 1975-10-04
AR206812A1 (es) * 1974-04-01 1976-08-23 Pfizer Compuestos intermediarios de azaciclo(3,4-a)indoles 4- y 5-fenil substituidos desprovistos de actividad terapeutica
US4001263A (en) * 1974-04-01 1977-01-04 Pfizer Inc. 5-Aryl-1,2,3,4-tetrahydro-γ-carbolines
SE7702301L (sv) * 1976-04-08 1977-10-09 Endo Lab Trans-hexahydro-pyrido-indoler
SE441448B (sv) * 1977-05-23 1985-10-07 Pfizer Sett att framstella hexahydro-gamma-karbolinforeningar

Also Published As

Publication number Publication date
IT1149927B (it) 1986-12-10
DD156369A5 (de) 1982-08-18
FR2453175A1 (fr) 1980-10-31
FR2453174A1 (fr) 1980-10-31
ATA33380A (de) 1984-05-15
HU188201B (en) 1986-03-28
YU242183A (en) 1984-06-30
SE8404554L (sv) 1984-09-11
LU82105A1 (fr) 1980-08-08
CH651040A5 (fr) 1985-08-30
HU189174B (en) 1986-06-30
PL126867B1 (en) 1983-09-30
IT8019373A0 (it) 1980-01-22
AT376674B (de) 1984-12-27
US4224329A (en) 1980-09-23
NO151895B (no) 1985-03-18
GB2041925A (en) 1980-09-17
SE8000329L (sv) 1980-07-24
GB2041925B (en) 1982-10-20
NZ197581A (en) 1984-05-31
JPS5636487A (en) 1981-04-09
JPS5855151B2 (ja) 1983-12-08
IN153300B (de) 1984-06-30
CA1144168A (en) 1983-04-05
DE3002367A1 (de) 1980-07-24
IL59189A (en) 1984-01-31
IE49500B1 (en) 1985-10-16
ZA796374B (en) 1980-11-26
NO794317L (no) 1980-07-24
NO843041L (no) 1980-07-24
SE441358B (sv) 1985-09-30
SU1168094A3 (ru) 1985-07-15
JPS5636486A (en) 1981-04-09
AU5476580A (en) 1980-07-31
FR2447379B1 (de) 1983-08-19
PL126032B1 (en) 1983-07-30
CS221806B2 (en) 1983-04-29
SE8404555L (sv) 1984-09-11
NZ192175A (en) 1984-05-31
JPS5636475A (en) 1981-04-09
JPS55100386A (en) 1980-07-31
PH17773A (en) 1984-12-11
NO151895C (no) 1985-06-26
AR231291A1 (es) 1984-10-31
CS221807B2 (en) 1983-04-29
IE800121L (en) 1980-07-23
JPS5740151B2 (de) 1982-08-25
SU1080746A3 (ru) 1984-03-15
GR73567B (de) 1984-03-16
CS221808B2 (en) 1983-04-29
PH15086A (en) 1982-07-02
BE881283A (fr) 1980-07-22
PL221248A1 (de) 1980-12-01
PT70724A (en) 1980-02-01
EG14767A (en) 1985-12-31
PH15072A (en) 1982-06-03
HU184712B (en) 1984-10-29
SE8404555D0 (sv) 1984-09-11
NL8000385A (nl) 1980-07-25
NZ197582A (en) 1984-05-31
PL120774B1 (en) 1982-03-31
AU521986B2 (en) 1982-05-13
SU1333239A3 (ru) 1987-08-23
SE8404554D0 (sv) 1984-09-11
FR2453174B1 (de) 1983-07-29
KR830001932A (ko) 1983-05-19
PH15736A (en) 1983-03-18
PL126532B1 (en) 1983-08-31
IL59189A0 (en) 1980-05-30
YU269379A (en) 1984-04-30
FR2447379A1 (fr) 1980-08-22
FR2453175B1 (de) 1983-07-29
DK25580A (da) 1980-07-24
DD149071A5 (de) 1981-06-24
CH648314A5 (fr) 1985-03-15
FI800179A (fi) 1980-07-24

Similar Documents

Publication Publication Date Title
CS221809B2 (en) Method of making the dextrorotary trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido/4,3-b/indole
JP2572591B2 (ja) 新規キノロン誘導体およびその塩
NZ203719A (en) N-(1-s-carboxyalk-3-yl)-alpha-aminoalkanoyl)perhydrocycloalkano(c)pyrrole-1-carboxylic acids
US4032575A (en) Benzylalcohol amine derivatives
EP1546149A1 (de) Modifizierte pictet-spengler-reaktion und damit hergestellte verbindungen
CZ261994A3 (en) 1-piperazine-1,2-dihydroindene derivatives, pharmaceutical composition containing thereof and use of said substances for preparing pharmaceutical preparations
FI63402B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara d- och d1-trans-5-fenyl-2,3,4,4a 5,9b-hexahydro-1h-pyrido(4,3-b)indolderivat
US4010202A (en) 5,6-Dihydroxy aminotetralol compounds
US4612312A (en) Glutarimide antianxiety and antihypertensive agents
US4614806A (en) Process for the asymmetric synthesis of chiral indoline-2-carboxylic acids
SE446003B (sv) Mellanprodukter for framstellning av hydroxiaminoeburnanderivat
JPH04211647A (ja) アミノベンゼン化合物
JPS6124579A (ja) 置換されたフエノキシアルキルアミノプロパノール
JPH0670032B2 (ja) アミノピロリジン誘導体、そのエステルおよびその塩
US4252812A (en) 2-Substituted-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indoles
US4267331A (en) Process for the production of 2-substituted pyrido[4,3-b]-indoles
JPH0560478B2 (de)
US4034100A (en) Antihypertensive agents
HU202228B (en) Process for producing 4-piperidinyl-methyl-derivatives of 2,3-dihydro-1h-isoindol and 2,3,4,5-tetrahydro-1h-benzazepines and pharmaceutical compositions containing them
JPH0674260B2 (ja) キノリン誘導体、そのエステルおよびその塩
JPH0635458B2 (ja) ピリドンカルボン酸誘導体、そのエステルおよびその塩
GB2126230A (en) Substituted 1-pyridyloxy-3- indolylakylamino-2-propanols, preparation, and use thereof
JPH0848629A (ja) ピリドンカルボン酸誘導体およびそれを有効成分とする抗ピロリ菌剤
US3976650A (en) Process for preparing optically active 6,7-dimethoxy-2-methyl-4-oxo-1,2,3,4-tetrahydro-1-quinoline carboxylic acid ester analgesics
JP3068175B2 (ja) イソチアゾロ〔５，４―ｂ〕ピリジン誘導体